Related Experiment Videos
[The TSH receptor gene and the pathogenesis of Graves' disease]
1First Department of Internal Medicine, Nagasaki University School of Medicine.
Abstract:
The molecular cloning of the thyrotropin (TSH) receptor cDNA has led to advances in understanding the structure and function of the molecule and the pathogenesis of autoimmune thyroid disease. The recombinant TSH receptors expressed on mammalian cells are now available for TSAb and TBIAb assays. TBI assay in this system is much more sensitive than the conventional method. The binding sites for TSH and TSAb/TBIAb have been studied with epitope library, synthetic peptides, anti-peptide sera and mutagenesis. Some of these data, however, are confusing and undefined. The binding sites for TSH and TSAb/TBIAb are very likely to span the entire region of the extracellular domain of the TSH receptor with discontinuous contact points, and seem to be different from each other on N-terminal half, but similar on C-terminal half, of the extracellular domain of the receptor. However, the determination of the precise amino acids involved may be very difficult without monoclonal anti-TSH receptor antibodies.
Insights
Recombinant thyrotropin (TSH) receptors improve autoimmune thyroid disease assays. Understanding TSH receptor binding sites is crucial for diagnosing and treating these conditions.
Area of Science:
- Endocrinology
- Molecular Biology
- Immunology
Context:
- The cloning of the thyrotropin (TSH) receptor cDNA has advanced the study of its structure, function, and the pathogenesis of autoimmune thyroid diseases.
- Recombinant TSH receptors expressed on mammalian cells are now utilized for thyroid-stimulating immunoglobulin (TSI) and TSH receptor antibody (TRAb) assays.
- The current TSH receptor antibody (TRAb) assay demonstrates significantly higher sensitivity compared to conventional methods.
Purpose:
- To explore the binding sites of TSH and TSI/TRAb on the TSH receptor.
- To analyze the structural characteristics of TSH receptor-antibody interactions.
- To identify challenges in precisely mapping amino acid residues involved in TSH and TSI/TRAb binding.
Summary:
- Studies using epitope libraries, synthetic peptides, anti-peptide sera, and mutagenesis suggest TSH and TSI/TRAb binding sites span the extracellular domain of the TSH receptor.
- These binding sites appear to involve discontinuous contact points.
- While distinct in the N-terminal half, the binding sites show similarities in the C-terminal half of the extracellular domain.
Impact:
- The development of sensitive assays for TSH receptor antibodies (TRAbs) aids in diagnosing and monitoring autoimmune thyroid diseases.
- Further characterization of TSH receptor binding sites is essential for understanding disease mechanisms.
- The precise determination of amino acids involved in TSH and antibody binding may require monoclonal anti-TSH receptor antibodies for clarity.